SURMOUNT-MAINTAIN (Horn 2026, 112 weeks): continued top dose -21.9% vs 5 mg step-down -16.6% vs placebo -9.9%, rescue therapy 8/25/67%: Aronne JAMA 2024
High Difficulty in Controlling Formulation Stability The peptide chain structure of Copper Tripeptide-1 is sensitive to ultraviolet light, strong acids, and metal ion interactions
5-Amino-1MQ is a small molecule, not a peptide, so it has no peptide bonds for digestive enzymes to cleave and can be studied orally as well as reconstituted for subcutaneous injection
sub-gram doses may support general antioxidant health but produce minimal visible skin change
Q3: Why hasn ' t GHK-Cu obtained FDA drug approval like some active ingredients
Koodziejska, R., Woniak, A., Bilski, R., Wesoowski, R., Kupczyk, D., Porzych, M., Wrblewska, W., & Pawluk, H